life science tools market

Laboratory Equipment is the largest segment driving the growth of life science tools market


The global life science tools market is estimated to be valued at US$ 111.28 billion in 2022 and is expected to exhibit a CAGR of 12.5% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Life science tools include instruments, consumables and software solutions used to conduct experiments and research in biotechnology, pharmaceutical and molecular biology applications. Laboratory equipment like spectrometers, preparative liquid chromatography systems, and molecular spectrometers form a core part of life science R&D activities and facilitate downstream analysis processes.

Market key trends:

Advancements in genomics and the emergence of precision medicine have boosted investments in life science research over the past decade. Growing demand for high-throughput screening, increasing automation and the transition towards lab informatics driven by Big Data analytics are some of the major trends shaping the market landscape. Adoption of microfluidics based point-of-care diagnostic platforms and wearable biosensors for real-time health monitoring also presents significant opportunities for growth during the forecast period.

Market key trends:

One of the key trends in the life science tools market is the increasing adoption of integrated lab solutions. Earlier, life science research involved the use of individual tools and instruments. However, with advanced technologies, various tools are now being integrated into single software platforms and systems. This integration allows researchers to perform multi-omics analysis in a single experiment with better efficiency and productivity. Various vendors are developing integrated lab solutions comprising instruments, consumables, software, and cloud-based data analysis. This growing integration of technologies is expected to drive significant changes in life science research workflows.

SWOT Analysis

Strength: Integrated lab solutions providing multi-omics analysis capabilities in a single experiment.
Weakness: High costs of advanced life science tools limit their adoption.
Opportunity: Growth in pharma and biotech R&D spending and increasing focus on precision medicine.
Threats: Stringent regulatory landscape increases compliance requirements for market players.

Key Takeaways

The Global Life Science Tools Market Size is expected to witness high growth, exhibiting CAGR of 12.5% over the forecast period, due to increasing R&D investments in drug development and growing focus on precision medicine.

Regional analysis: North America dominated the market in 2022 with a share of over 35%, followed by Europe. Asia Pacific is expected to grow at the fastest pace during the forecast period due to increasing research activities and expansions by key market players in countries like China and India.

Key players operating in the life science tools market are Agilent Technologies, Inc., BD, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments, ZEISS International, Genome Medical, Inc., Hamilton Company, and Beckman Coulter, Inc.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it